• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHL2400107 美洛昔康注射液 meloxicam Injection Chemical Drugs(3) Generic Drug 2024-06-12 Zhejiang Sundoc Pharmaceutical Science And Tech Co Ltd view
CYHS2400303 美洛昔康注射液 meloxicam Injection Chemical Drugs(3) Generic Drug 2024-01-23 Cspc Heibei Zhongrun Pharmaceutiacl Co Ltd view
CYHL2300128 美洛昔康注射液 meloxicam Injection Chemical Drugs(3) Generic Drug 2023-10-11 QILU Pharmaceutical Co Ltd view
CXHS2300077 美洛昔康注射液 meloxicam Injection Chemical Drugs(2.2) New Drug Application 2023-09-08 view
CXHL2200979 美洛昔康注射液 meloxicam Injection Chemical Drugs(2.2) New Drug Application 2022-12-30 Beijing Tide Pharmaceutical Co Ltd view
CXHB2200155 QP001注射液 meloxicam Injection Chemical Drugs(2.2) Supplementary Application 2022-09-14 Nanjing Delova Biotech Co Ltd view
CXHL2100060 QP001注射液 meloxicam Injection Chemical Drugs(2.2) New Drug Application 2021-01-27 南京清普生物科技有限公司 Nanjing Delova Biotech Co Ltd In Review 2021-01-26 view
JYHF2000087 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2020-09-30 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Filed 2020-10-21 view
JYHB2000816 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2020-06-12 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-06-19 view
JYHZ2000026 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2020-03-11 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-31 view
JYHZ2000027 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2020-02-25 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-31 view
JYHB1800215 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2018-03-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2018-06-12 view
JYHB1800213 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2018-03-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2018-03-15 view
JYHB1600223 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2016-02-29 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Certificate Issued 2017-03-14 view
JYHB1600224 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2016-02-16 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Certificate Issued 2017-03-14 view
JYHZ1400688 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2014-12-15 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Certificate Issued 2015-10-19 view
JYHZ1400689 美洛昔康注射液 meloxicam Injection Chemical Drugs License Renew 2014-12-08 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Certificate Issued 2015-10-19 view
JYHB1401492 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2014-11-05 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Certificate Issued 2015-08-24 view
JYHB1401491 美洛昔康注射液 meloxicam Injection Chemical Drugs Supplementary Application 2014-11-05 上海勃林格殷格翰药业有限公司 Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Certificate Issued 2015-08-24 view
CYHL1400002 美洛昔康注射液 meloxicam Injection Chemical Drugs(6) Generic Drug 2014-08-01 宁夏康亚药业有限公司 Kangya of Ningxia Pharmaceutical Co Ltd Certificate Issued 2017-09-20 view